2-amino-5-phosphonovalerate has been researched along with aspartame in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Mohanna, FA; Andres, B; Collison, KS; Inglis, A; Mata, P; Shibin, S; Thiam, J; Ubungen, R | 1 |
| Al-Mohanna, FA; Andres, B; Collison, KS; Inglis, A; Mata, P; Saleh, S; Shibin, S; Thiam, J; Ubungen, R | 1 |
2 other study(ies) available for 2-amino-5-phosphonovalerate and aspartame
| Article | Year |
|---|---|
Differential effects of early-life NMDA receptor antagonism on aspartame-impaired insulin tolerance and behavior.
Topics: 2-Amino-5-phosphonovalerate; Animals; Animals, Newborn; Aspartame; Behavior, Animal; Blood Glucose; Dark Adaptation; Excitatory Amino Acid Antagonists; Exploratory Behavior; Female; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Recognition, Psychology; Statistics, Nonparametric; Sweetening Agents | 2016 |
Effect of developmental NMDAR antagonism with CGP 39551 on aspartame-induced hypothalamic and adrenal gene expression.
Topics: 2-Amino-5-phosphonovalerate; Animals; Aspartame; Female; Gene Expression Regulation; Hypothalamo-Hypophyseal System; Male; Mice; Pituitary-Adrenal System; Receptors, N-Methyl-D-Aspartate | 2018 |